Satellos Bioscience's total assets for Q1 2025 were C$44.37M, a decrease of -39.24% from the previous quarter. MSCLF total liabilities were C$2.70M for the fiscal quarter, a -47.64% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.